During the past decade, UT Southwestern Simmons Cancer Center - RedBird conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UT Southwestern Simmons Cancer Center - RedBird" are "Sarcomatoid Renal Cell Carcinoma" (2 trials), "Stage IV Renal Cell Cancer AJCC v8" (2 trials), "Bladder Adenocarcinoma" (1 trials), "Bladder Clear Cell Adenocarcinoma" (1 trials) and "Bladder Mixed Adenocarcinoma" (1 trials). Many other conditions were trialed in "UT Southwestern Simmons Cancer Center - RedBird" in a lesser frequency.

Most popular intervention types in "UT Southwestern Simmons Cancer Center - RedBird" are "Biological" (2 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (2 trials), "Ipilimumab" (2 trials), "Magnetic Resonance Imaging" (2 trials), "Nivolumab" (2 trials) and "Biospecimen Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "UT Southwestern Simmons Cancer Center - RedBird" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UT Southwestern Simmons Cancer Center - RedBird". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UT Southwestern Simmons Cancer Center - RedBird, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UT Southwestern Simmons Cancer Center - RedBird, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".